Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Trichoscopy effectively diagnoses and assesses hair loss severity in androgenetic alopecia and alopecia areata.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

No significant link between male pattern baldness and COVID-19 severity was found.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

The Trichoscopy Derived Sinclair Scale offers a more accurate and reliable way to measure hair loss severity than the traditional visual method.

58% of men aged 30-50 have hair loss, with severity increasing with age.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Digital imaging can effectively evaluate the donor area for hair transplants, showing variations in hair density and grouping by age and severity of hair loss.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

The paper suggests a way to diagnose male hair loss and check treatment results using a dermoscope at four specific scalp points.